-

MedImpact Includes MedEmpower Fuel™ Health and Wellness App as a Standard Part of Pharmacy Benefit Services

Award-winning nutrition and wellness platform available to clients at no additional cost, with optional clinical bundles for people with cancer, hypertension, and other chronic conditions

SAN DIEGO--(BUSINESS WIRE)--MedImpact, the leading independent pharmacy benefit and health solutions company, today announced that MedEmpower Fuel™, its award-winning digital health and wellness platform, is now a standard component of its pharmacy benefit services—available at no cost to clients and members.

MedImpact includes MedEmpower Fuel™ #health and #wellness app as a standard part of pharmacy benefit services.

Share

“By embedding MedEmpower Fuel as a benefit, MedImpact is looking beyond the prescription to deliver a solution that not only enhances member satisfaction and health outcomes, but also helps payers improve member health and reduce overall healthcare costs,” said Zach Johnson, MedImpact Executive Vice President. “It’s personalized, engaging, and innovative—exactly what’s needed to drive sustainable change.”

This offering comes at a critical time. The widespread adoption of GLP-1 medications for obesity and diabetes has placed a heavy and growing financial burden on payers. These medications, while effective, come with significant long-term cost implications. If a patient with obesity discontinues treatment—as at least half do within the first year—they typically regain the lost weight, according to the Journal of the American Medical Association (JAMA).

The MedEmpower Fuel app empowers individuals to make healthier choices by providing personalized meal planning, activity tracking, and behavioral coaching—all designed to support weight management, chronic disease prevention, and medication adherence. By integrating this app into the pharmacy benefit design, MedImpact aims to reduce long-term healthcare costs by addressing the root causes of high-cost conditions.

In addition to the nutrition and wellness platform now a part of MedImpact’s core pharmacy benefit, MedEmpower Fuel also offers clinical condition management programs tailored specifically for people with hypertension, cancer, autoimmune disease, and behavioral health challenges with one-on-one coaching. And while these supplemental bundles are available to health plans at an additional cost, they provide personalized clinical support to people with the most complex and costly health challenges.

MedEmpower Fuel is one part of MedImpact’s enterprise-wide strategy to deliver lower costs and improved access for members, payers, and pharmacies. This includes providing wholesale access to biosimilars to any specialty pharmacy, more flexible and cost-effective formulary choices, and price guarantees, among other features. An independent company with scale, clinical strength, and advanced technology, MedImpact is uniquely able—and driven—to offer this combination of solutions, technology, accountability, and transparency.

“The status quo is just not enough,” continued Johnson. “MedEmpower Fuel reflects our commitment to innovation, integration, and impact—blending pharmacy, behavioral, and nutritional insights into one seamless experience that supports members where they are.”

MedEmpower Fuel is immediately available to MedImpact clients.

About MedImpact

San Diego-based MedImpact Healthcare Systems, Inc. is the nation’s largest independent health solutions, technology, and pharmacy benefit management provider. For 35 years, MedImpact has helped commercial and government healthcare payers improve member health, manage benefits, and reduce drug costs. Today, MedImpact serves more than 20 million members and processes more than $40 billion in pharmacy transactions annually. To learn more, visit us online, follow us on LinkedIn, or contact us at info@MedImpact.com.

Contacts

Jennifer Kroll, jkroll@jwa.co

MedImpact Healthcare Systems, Inc.


Release Versions

Contacts

Jennifer Kroll, jkroll@jwa.co

Social Media Profiles
More News From MedImpact Healthcare Systems, Inc.

MedImpact Offers Low Cost, Unbranded Ustekinumab-aekn Biosimilar to Any Specialty Pharmacy in the US

SAN DIEGO--(BUSINESS WIRE)--MedImpact Holdings Inc. today announced that it will have access to an unbranded biosimilar ustekinumab-aekn at a significantly lower cost than the reference Stelara® (ustekinumab). The biosimilar, distributed by Anda, an affiliate of Teva Pharmaceuticals USA, Inc., will be available for direct purchase from MedImpact’s preferred partner, Birdi, Inc., by any licensed specialty pharmacy. “Today, a drug’s cost rises at each step in the supply chain,” said Arpit Patel,...

MedImpact Expands Leadership Team to Advance Its Vision to Transform Pharmacy Benefits and Offer Clients a Modular Portfolio of Connected Healthcare Solutions

SAN DIEGO--(BUSINESS WIRE)--MedImpact, the nation’s largest independent pharmacy benefit, health, and technology solutions company, today announced key new hires and promotions to build on the company’s recent investments and bring new levels of innovation, clinical excellence, flexibility, and control to healthcare payers, providers, and members. “We are building a broad and modular suite of clinical, cost management, and consumer solutions—all powered by the best technology in the industry—an...

MedImpact Achieves NCQA UM Accreditation Three-Year Renewal

SAN DIEGO--(BUSINESS WIRE)--MedImpact, the nation’s largest independent pharmacy benefit and health solutions company, announced today that it has earned a three-year reaccreditation in Utilization Management from the National Committee for Quality Assurance (NCQA). This marks MedImpact’s fourth consecutive NCQA UM Accreditation. “Achieving NCQA Utilization Management Accreditation demonstrates that MedImpact has the systems, processes, and personnel in place to conduct utilization management i...
Back to Newsroom